EGFR and cancer: This study identified Canadian patients with non-squamous NSCLC at the largest cancer treatment centre in Canada and described the real-world characteristics, treatment patterns, and clinical outcomes for patients with advanced ex19del, exon 21 L858R, and ex20ins EGFR mutations using AI-extracted data.